Home › Breast Cancer › NCT05561842
Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)
RecruitingObservational study
Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria
Who can join
Ages 18 and older · Women
Full eligibility criteria
Inclusion Criteria: * Age 18 and older female. * Breast ultrasound demonstrating a solid mass that is suspicious for cancer, which would typically undergo either a blind biopsy or surgical excision at the Nigerian hospital where the patient is seeking diagnosis. Exclusion Criteria: * Participants unwilling to sign consent. * Participants under the age of 18.
About the study
The purpose of this study is to train Nigerian radiologists to perform ultrasound-guided breast biopsies. Researchers will use mHealth devices to create a sustainable and practical way of training radiologists in Nigeria to perform and clinically implement US-guided breast biopsies into their practice.
What is being tested
- mHealth US-breast biopsy (procedure)
Sponsor: Memorial Sloan Kettering Cancer Center · Participants: 900 · Started: Sep 21, 2022
Contact the study team
- Elizabeth Sutton, MD · Phone: 646-888-5455
- Yolana Bryce, MD · Phone: 212-639-6530
Official record on ClinicalTrials.gov — NCT05561842
Locations in the U.S.
| New York | Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.